The clinical trial conducted by Johns Hopkins University explores the feasibility and efficacy of acupressure and acupuncture as interventions for children with ASD. Given the increasing prevalence of ASD and the growing demand for alternative therapies, this study addresses a significant market need. The results could position the sponsor favorably within the complementary and alternative medicine sector, particularly if positive outcomes are demonstrated. However, the competitive landscape includes various behavioral and pharmacological interventions, necessitating a thorough market analysis and strategic positioning to differentiate these modalities. Diligence should focus on regulatory pathways and potential reimbursement scenarios for non-conventional therapies.